Acthib, Omnihib Market Report 2026

Acthib, Omnihib Market Overview

• The Acthib, Omnihib market growth in the historic period has been driven by high burden of hib related infections, proven vaccine effectiveness • Market expansion is supported by continued focus on infant immunization coverage, expansion in emerging economies • Growth Driver: Rising Prevalence Of Haemophilus Influenzae Type B (Hib) Infections Enhanced Acthib Omnihib Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Acthib, Omnihib Market?

ActHIB and OmniHIB are both vaccines used to prevent invasive diseases caused by Haemophilus influenzae type b (Hib), such as meningitis and pneumonia. ActHIB is a conjugate vaccine containing the Hib capsular polysaccharide conjugated to a protein, while OmniHIB is a similar conjugate vaccine. Both are typically administered to infants and children for immunity. They are crucial in reducing Hib-related illnesses, which can be severe or fatal. The main vaccine types of acthib, omnihib are monovalent Hib vaccines and combination vaccines. Monovalent Hib vaccines are designed to protect against infections caused by Haemophilus influenzae type b (Hib) alone. These vaccines contain a specific component of the Hib bacterium, which helps the immune system recognize and fight the infection. Clinical indications include Haemophilus Influenzae Type B (HIB) Infection. The age group includes infants and toddlers, and adults and end users include hospitals, clinics, and retail pharmacies.

What Is The Acthib, Omnihib Market Growth Forecast?

The growth in the forecast period can be attributed to continued focus on infant immunization coverage, expansion in emerging economies, government supported vaccination campaigns, improved vaccine access logistics, rising awareness of bacterial meningitis prevention. Major trends in the forecast period include sustained demand for routine pediatric immunization, rising adoption of combination childhood vaccines, expansion of national immunization programs, improved vaccine cold chain infrastructure, growing focus on preventable bacterial infections.

Global Acthib, Omnihib Market Segmentation

1) By Type Of Vaccine: Monovalent Hib Vaccines, Combination Vaccines 2) By Clinical Indication: Haemophilus Influenzae Type B (HIB) Infection 3) By Age Group: Infants And Toddlers, Adults 4) By End-User: Hospitals And Clinics, Retail Pharmacies

What Are The Drivers Of The Acthib, Omnihib Market?

The increasing prevalence of haemophilus influenzae type b (Hib) infections is expected to propel the growth of the acthib, omnihib market going forward. Haemophilus influenzae type b (Hib) infections refer to severe bacterial infections caused by Haemophilus influenzae type b, leading to conditions such as meningitis, pneumonia, and epiglottitis, primarily affecting young children. The increase in haemophilus influenzae type B (Hib) infections is due to reduced vaccination rates, as lower immunization uptake weakens community protection and increases susceptibility to infection. ActHIB, omniHIB are used for haemophilus influenzae type B (Hib) infections because they protect by stimulating the immune system to recognize and fight the Haemophilus influenzae type b bacteria. For instance, in October 2025, according to a Australian Institute of Health and Welfare, an Australia-based independent statutory government agency, in 2023, 94% of Australian 1-year-olds and 93% of 2-year-olds were fully vaccinated against Hib. Therefore, the increasing prevalence of Haemophilus influenzae type b (Hib) infections is fueling the acthib, omnihib industry. The rising healthcare expenditure is expected to propel the growth of the acthib, omnihib market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure enhances the acthib, omnihib market by enabling broader access to routine immunizations and strengthening national vaccination programs. It supports greater investment in pediatric preventive care, allowing governments and healthcare systems to expand Hib vaccine coverage and improve supply availability. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the acthib, omnihib industry. The increasing research and development activities are expected to propel the growth of the acthib, omnihib market going forward. Research and development activities involve the systematic exploration and development of new knowledge, products, or technologies through research and experimentation. The increasing research and development activities are due to the growing demand for safer, more effective therapies that improve patient outcomes and enhance treatment precision. Research and development activities enhance the acthib, omnihib market by improving vaccine formulations, strengthening immunogenicity, and supporting better production efficiency. They enable manufacturers to optimize conjugation technologies, extend vaccine stability, and advance combination vaccine options, ultimately improving protection against Hib infections and expanding accessibility in global immunization programs. For instance, in July 2025, according to Eurostat, a Luxembourg-based statistical agency, the total government budget allocations for R&D across the EU reached an estimated €127,916 million in 2024, marking a 3.4% increase compared with €123,675 million in 2023. Therefore, the increasing research and development activities is driving the growth of the acthib, omnihib industry.

Key Players In The Global Acthib, Omnihib Market

Major companies operating in the acthib, omnihib market are Sanofi SA

Regional Insights

North America was the largest region in the acthib, omnihib market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Acthib, Omnihib Market?

The acthib, omnihib market consists of sales of Hib vaccines, boosters, and pediatric vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acthib, Omnihib Market Report 2026?

The acthib, omnihib market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acthib, omnihib industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.